Skip to content

FoodSteps for Binge Eating & Food Insecurity

Evaluating a Digital Intervention for Binge Eating and Weight Management Among Adults With Food Insecurity

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06348251
Enrollment
31
Registered
2024-04-04
Start date
2024-03-26
Completion date
2024-11-20
Last updated
2026-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Binge Eating, Food Insecurity, Type 2 Diabetes

Brief summary

The purpose of this study is to conduct a pilot trial of a mobile intervention that targets binge eating and weight-related behaviors, to determine the feasibility, acceptability, and preliminary efficacy of the intervention among adults with recurrent binge eating, diabetes, and food insecurity.

Interventions

BEHAVIORALFoodSteps

Participants will get access to the FoodSteps digital intervention with coaching for 16 weeks and receive a weekly stipend benefit to aid with implementing health behavior changes

Sponsors

Northwestern University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults age 18 years or older * Recurrent binge eating (≥12 episodes in the past 3 months) * Type 2 diabetes mellitus * Food insecure status (e.g. difficulty accessing food) * Interested in losing weight and reducing binge eating * Willing to use a mobile application * Has a smartphone with Internet access and capacity for calls and text messaging * Has a valid email address * Not pregnant * English-speaking

Exclusion criteria

* Diagnosis for which the study/intervention is not clinically indicated * Currently receiving clinical services for weight management or binge eating * Started or recently (within the past month) changed dosage of a medication for binge eating, weight management, or diabetes

Design outcomes

Primary

MeasureTime frameDescription
Recruitment Rate16 weeksFeasibility assessed by study recruitment and retention rates
Study Retention Rate16 weeksFeasibility assessed by study recruitment and retention rates

Countries

United States

Baseline characteristics

Characteristic
Age, Continuous47.45 Years
STANDARD_DEVIATION 11.72
Ethnicity (NIH/OMB)
Hispanic or Latino
5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
26 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
3 Participants
Race (NIH/OMB)
Asian
1 Participants
Race (NIH/OMB)
Black or African American
9 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
17 Participants
Sex/Gender, Customized
Female
23 Participants
Sex/Gender, Customized
Male
7 Participants
Sex/Gender, Customized
Not reported as male or female
1 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 31
other
Total, other adverse events
0 / 31
serious
Total, serious adverse events
0 / 31

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 18, 2026